MNMD - Mind Medicine (MindMed) Inc. - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

437.1M

Cash

252.3M

Avg Qtr Burn

-16.91M

Short % of Float

15.74%

Insider Ownership

1.19%

Institutional Own.

48.94%

Qtr Updated

03/31/24

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
MM120 (lysergide D-tartrate) Details Anxiety Disorders	Phase 3 Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
MM402 (R(-)-MDMA) Details Autism spectrum disorders	Phase 1 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.